Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 36)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A AVCA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Avanti Capital PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Real Estate & Construction Industry Market Research and Competitive Analysis 2009 599 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Real Estate & Construction Industry Trends, Statistics & Analysis 2009 (Summary) 64 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADVOCAT INC 5 $25 View Abstract
Next 20

Brokerage Reports (Showing 1 to 5 of 5)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
10-Nov-09 Thomson StreetEvents N/A AVCA - Event Transcript of Advocat conference call, Nov. 10, 2009 / 10:00am ET 8 $75 View Abstract
2-Nov-09 Morgan Keegan & Company, Inc. N/A First Look - Nov 02 2009 08:11AM 11 $25 View Abstract
2-Nov-09 Morgan Keegan & Company, Inc. Rob M. Mains CFA NHC RHB SKH SUNH: The Final MPFS and Therapy Services 7 $25 View Abstract
9-Oct-09 Morgan Keegan & Company, Inc. N/A First Look - Oct 09 2009 08:25AM 5 $10 View Abstract
9-Oct-09 Morgan Keegan & Company, Inc. Rob M. Mains CFA HCP, NHC, SKH, SUNH: The Return of HCR Manor Care? 5 $10 View Abstract

Independent Reports (Showing 1 to 10 of 31)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A AVCA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Reuters Investment Profile N/A Avanti Capital PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Real Estate & Construction Industry Market Research and Competitive Analysis 2009 599 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Real Estate & Construction Industry Trends, Statistics & Analysis 2009 (Summary) 64 $199 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 103 $169 View Abstract
22-Nov-09 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 101 $169 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: ADVOCAT INC 5 $25 View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.